DotBio
PrivateLast Round
Early Funding
Aug 7, 2023
Total Funding Raised
$8.45M
Company Overview
DotBio is a biotechnology company that develops multi-functional and intracellular antibody therapies for immuno-oncology and other therapeutic areas using its proprietary DotBody modular platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DotBio Comparables
Compare DotBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aarvik Therapeutics | 83% | |
| Crescendo Biologics Ltd. | 82% | |
| Chantibody Therapeutics | 79% | |
DotBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 7, 2023 | ||||
| Grant | Oct 23, 2020 | ||||
| Corporate Funding | Sep 15, 2020 | ||||
| Seed | Jul 30, 2018 |
Key People
Founding team and executive leadership
DotBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Grant |
| NTUitive | Seed |
| National Foundation for Cancer Research | Early Funding |
| Gaorong Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2023
$5.6M raised led by Gaorong Capital and aim-hiaccelerator.
- Jul 30, 2018
$2.3M raised from ASLAN Pharmaceuticals and NTUitive.
DotBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DotBio's valuation, stock price, and market status.